文献速递临床微生物分子诊断临床免疫

基于机器学习的电子鼻检测新生儿脓毒症:粪便挥发性有机化合物生物标志物分析

A machine learning-based electronic nose for detecting neonatal sepsis: Analysis of volatile organic compound biomarkers in fecal samples.
PubMed 文献 · Clin Chim Acta · 2024-09-24

本研究开发了一种基于金属氧化物半导体的电子鼻(cNose),结合GC-MS鉴定的挥发性有机化合物(VOC)生物标志物,用于无创、快速检测新生儿脓毒症。系统在32例粪便样本(17例血培养阳性、15例阴性)中评估,采用四种机器学习算法,MLPNN模型表现最佳,交叉验证准确率90.63%、灵敏度88.24%、特异度93.33%。

要点

  • cNose电子鼻结合VOC标志物可无创、快速、低成本检测新生儿脓毒症。
  • MLPNN模型在32例粪便样本中区分脓毒症阳性与阴性,准确率90.63%。
  • GC-MS鉴定了与新生儿脓毒症相关的醇类、酸类和酯类VOC。

核心结论

  • cNose系统作为实时床旁脓毒症检测工具具有可行性,可能改善患者结局。

研究设计与样本

  • 研究采用实验室自建的金属氧化物半导体电子鼻(cNose),结合GC-MS鉴定的VOC生物标志物,评估粪便样本。
  • 共纳入32例粪便样本,包括17例血培养确诊脓毒症阳性和15例阴性,采用四种机器学习算法进行判别分析。

主要发现

  • MLPNN模型在交叉验证中表现最佳,区分新生儿脓毒症阳性与阴性的准确率为90.63%、灵敏度88.24%、特异度93.33%(95%CI)。
  • GC-MS分析成功鉴定了与新生儿脓毒症相关的特定VOC,包括醇类、酸类和酯类。

关键数值与推荐

  • MLPNN模型交叉验证结果:准确率90.63%、灵敏度88.24%、特异度93.33%(95%CI)。
  • 样本量:总32例,阳性17例,阴性15例,均经血培养确认。

临床怎么用

  • cNose系统可作为床旁实时检测工具,用于新生儿脓毒症的无创筛查。
  • 基于粪便VOC谱的机器学习分析可能辅助早期识别脓毒症,减少对侵入性、集中化检测的依赖。

局限性

  • 样本量较小(共32例),需更大规模研究验证。
  • 研究采用实验室自建设备,尚未在临床环境中广泛验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neonatal sepsis is a global health threat, contributing to high morbidity and mortality rates among newborns. Recognizing the profound impact of neonatal sepsis on long-term health outcomes emphasizes the critical need for timely detection to mitigate its consequences and ensure optimal health for the affected newborns. Currently, various diagnostic approaches have been implemented, but they are limited by their invasiveness, high costs, centralized testing, frequent delays, inaccuracies in results, and the need for sophisticated laboratory equipment. METHODS: We introduced a novel, non-invasive, cost-efficient, and easy-to-use technology that can provide rapid results at a point-of-care. The technology utilized a lab-built metal oxide semiconductor-based electronic nose (cNose) combined with volatile organic compound (VOC) biomarkers identified through gas chromatography-mass spectrometry (GC-MS) analysis. The system was evaluated using fecal profiling tests involving a total of 32 samples, including 17 positive and 15 negative sepsis, confirmed by blood culture. To assess the performance in discriminating patients from healthy controls, four machine learning algorithms were implemented. RESULTS: Based on the cross-validation results, the MLPNN model provided the best results in distinguishing between neonates with positive and negative sepsis, achieving high-performance results of 90.63 % accuracy, 88.24 % sensitivity, and 93.33 % specificity at a 95 % confidence interval. Specific VOCs associated with neonatal sepsis, such as alcohols, acids, and esters, were successfully identified through GC-MS analysis, further validating the diagnostic capability of the cNose device. CONCLUSION: The overall observations show the feasibility of using cNose system as a promising tool for real-time and bedside sepsis detection, potentially improving patient outcomes.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Othman Kombo K, Nur Hidayat S, Puspita M, et al. A machine learning-based electronic nose for detecting neonatal sepsis: Analysis of volatile organic compound biomarkers in fecal samples. Clin Chim Acta. 2024. PMID: 39326694. doi:10.1016/j.cca.2024.119974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。